ECONOMIC EVALUATION OF HYSTERECTOMY IN THE REAL CLINICAL PRACTICE- ROBOT-ASSISTED VERSUS CONVENTIONAL LAPAROSCOPIC
Author(s)
Jódar-Sánchez F1, García-Agua Soler N2, Martínez-Maestre MA1, Melero-Cortés LM1, Coronado PJ3, Garcia-Ruiz A2
1Virgen del Rocío University Hospital, Seville, Spain, 2University of Málaga, MALAGA, Spain, 3San Carlos Clinic Hospital, MADRID, Spain
OBJECTIVES: The aim of this study is to carry out the economic evaluation, in term of a cost-minimization analysis that considers healthcare costs and indirect costs, of robot-assisted hysterectomy (RAH) compared with conventional laparoscopic hysterectomy (CLH) in female adults scheduled for total laparoscopic hysterectomy for benign conditions. METHODS: Cost-minimization analysis based on an analytic observational study of prospective cohorts with a five-year time horizon. Eligible participants were all female adults scheduled for total laparoscopic hysterectomy for benign conditions at tertiary hospital. The economic evaluation was conducted from a Spanish National Health Service and societal perspective, including healthcare costs and indirect costs. The costs are expressed in Euros from the year 2015. RESULTS: 169 patients were analyzed, 68 in the RAH group and 101 in the CLH group. Average cost for the RAH group was €8,982.42 compared to €8,015.14 for the CLH group (incremental cost €967.27; p=0.054). Healthcare cost is the most important component of total cost and represents 86.4% for the RAH group and 82.3% for the CLH group. The difference of €1,169 (p=0.01) in the average healthcare cost is mainly due to the cost of purchasing and maintaining the equipment (difference of €1,206.39 in favor of RAH; p<0.005). With regard to indirect costs, for patients in the RAH group the costs associated with loss of productivity were lower (difference of €203.42; p=0.17), while the cost of trips to the hospital was higher (difference of €1.98; p=0.66) in respect to CLH. CONCLUSIONS: Our findings reveal similar effectiveness between RAH and CLH, although CLH is the more efficient option from the point of view of an economic analysis based on cost-minimization.
Conference/Value in Health Info
2019-11, ISPOR Europe 2019, Copenhagen, Denmark
Code
PSU10
Topic
Clinical Outcomes, Economic Evaluation, Health Service Delivery & Process of Care, Patient-Centered Research
Topic Subcategory
Comparative Effectiveness or Efficacy, Hospital and Clinical Practices, Patient-reported Outcomes & Quality of Life Outcomes
Disease
Oncology
Explore Related HEOR by Topic